• Human RARRES1 (Retinoic Acid Receptor Responder 1) Sandwich ELISA Kit Ready-To-Use (STJE0018221)

Human RARRES1 (Retinoic Acid Receptor Responder 1) Sandwich ELISA Kit Ready-To-Use (STJE0018221)

SKU:
STJE0018221

Shipping:
Free Shipping
Current Stock:
Applications: ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Sensitivity: 0.066ng/mL
Detection Limit: 0.156-10ng/mL
Short Description: This RARRES1 Sandwich ELISA Kit, Ready-To-Use is an in-vitro enzyme-linked immunosorbent assay for the measurement of samples in human cell culture supernatant, serum and plasma (EDTA, citrate, heparin).
Storage Instruction: The whole kit may be stored at-20°C for up to 12 months from receipt. An unopened kit may be stored in the fridge at 2-8°C for up to 6 months. Once opened store individual kit contents according to components table provided with the kit.
Assay Time: 3 hrs
Gene Symbol: RARRES1
Gene ID: 5918
Uniprot ID: TIG1_HUMAN
Immunogen Region: Ready-To-Use
Sample Type: serum, plasma, tissue homogenates or other biological fluids.
Tissue Specificity Detected in urine (at protein level).
Post Translational Modifications Not N-glycosylated. O-glycosylated.contains chondroitin sulfate.
Function Inhibitor of the cytoplasmic carboxypeptidase AGBL2, may regulate the alpha-tubulin tyrosination cycle.
Protein Name Retinoic Acid Receptor Responder Protein 1
Phorbol Ester-Induced Gene 1 Protein
Perg-1
Rar-Responsive Protein Tig1
Tazarotene-Induced Gene 1 Protein
Database Links
Cellular Localisation Membrane
Single-Pass Type Iii Membrane Protein
Secreted
Alternative ELISA Names Retinoic Acid Receptor Responder Protein 1 ELISA kit
Phorbol Ester-Induced Gene 1 Protein ELISA kit
Perg-1 ELISA kit
Rar-Responsive Protein Tig1 ELISA kit
Tazarotene-Induced Gene 1 Protein ELISA kit
RARRES1 ELISA kit
PEIG1 ELISA kit
TIG1 ELISA kit
output

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance